Curi RMB Capital’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
ACM
KGAMU
Curi RMB Capital's CDLX Position: Q1 2021 in Review
Curi RMB Capital sold out of Cardlytics (CDLX) in Q1 2021, closing a stake of 2,402 shares — an estimated $3.43M sold.
Curi RMB Capital first reported a position in CDLX in Q3 2019 and held it in 6 quarters. The position peaked at $4.76M in Q4 2019. 204 funds tracked by Wall St. Rank hold CDLX as of Q1 2021.
- Curi RMB Capital reported no remaining Cardlytics position as of Q1 2021 after selling out during the quarter.
- Curi RMB Capital sold 2,402 Cardlytics shares in Q1 2021, an estimated $3.43M.
- Curi RMB Capital first reported a position in Cardlytics in Q3 2019 and held it in 6 quarters.
- Curi RMB Capital's Cardlytics position peaked at $4.76M in Q4 2019.
- 204 funds tracked by Wall St. Rank held Cardlytics as of Q1 2021.
Based on Curi RMB Capital's 13F filing for Q1 2021, filed 12 May 2021.